Charles Bhatt

Charles Bhatt investigates proton therapy applications for breast cancer, focusing on cardiac dose reduction as a primary benefit. His research has quantified cardiac and pulmonary toxicity reduction achievable with proton versus photon radiation for left-sided breast cancer and locally advanced disease. He conducts health economics analyses of proton therapy value and cost-effectiveness, contributing evidence to insurance coverage debates. His multi-institutional studies on proton therapy outcomes for breast cancer are informing national treatment guideline development.